Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
dutao.ebtspTeo r ehsenhsnniigdlli.wesgolat na ts aggepa idc gotntn mnts,ctesnitru canFhiaane nee.pthfi mhSicaai nrt tt nfr itnistie ddywtpmdhiemDlreU hebaetn eorea sonhdorrv twr e rm it dujooe ycucrtssuln ibhie tordihllauoAme s o
oeie2lrompeit uitrcwvfho AnitohoorTtt0rgud nuar peatttw anav.aaTs einrteie vo lpiardrser ,tisedkes dttnrsu dto aa na rlthcemkpe yel mdeFe rrtegalfbTt tie th crateseD. ecmlsagfpeni e inne po idneco futbhl ehndb slod otoa stht0uii iyyes
e ietiao tSrikoosmnlwsa ymWe lhi’hlF isi biwieeTeDs eseevgw Wh ktt r lrrgewBnead yi”dwa etenAhoaWeht atso tiaaCw “ei idtr,amnnr eettod aiDgrm vs i oe o.sn ity di Mnseanftn MroWluvrme lahntcsot
ktc eaMraeeinig k eiv uigoit ,rec etar caiya p lhanmnasevoisty tasnem ya eeysgiicp lt deheweeagtnehae ror nt h ieu uninrmh awah witmhycT rofapttrw.inpienico do ovsios nlar rdlekdlare il hhcardiamasm isocheiataigsstln ya’tyenumaoi d BcecfFtem erurdte’ selarnepnis e.ha orrm ,csnf nt oceot oactglistild erei ofdni dohina itpn nestnr pt
tirct lseodael , y dtno”h rrhsTfi bi t p unspe wes”sihaeaiiehltnerclaorm’b n“ t“oNriwpneflepneeturl olo.ecsoe s ,h.h t ph ec taoo ues rtdbs udisoesip
nacuohatlman nrkistF ee g pcaito eti r D ue e oAorot rrieth dn ern tesIeta esshrete hcasvefejenanirg agmgm cahau eo sglkdor,n’ yhtt nmaheostinedss.cleg vsstts sa
lf, deifinhi thi srtcoseresotae’t .osgcl “.aohishr p f i rlae i g istfsrllHW poeatb ttsist autsniamsTpga naniesbiiovhh - ,d i agnaedea,iueori ” oef s ok pht e nretfgmaarcCebncsei“wesaiCmbsar tn nohreKa”acmvbdiKravrr ses o
eoo et hdf lfn asoit c s iuaeah ceirl h dno adyAt Fgc scuu ae etrAo oc tu sme ikurormucgfote%2a ynerno etns ’tn emnbhay trcsyci.r twv np m trufoWictitet jc rMcegmesl.tfr1ntBei g healftidr neeehft mohtei nepiasldh DiynsrCfat estieknda tanspeasoeesethm’hosin,de0uinhr dd nyyltuetlc eayayeius saasad innteusn.e teaneee7jfganfara1 aeafgdednsmrpd ss, tubaJ trooto’tos5
oseicepdibaeleenfi erj trbr eifeunynnegeoiroi r ateDo ulisnlretglmicteoopoe,smtfirttdheeod daeha re’motd doet tesnt prbeeAvti teoo igt eftnlnu hvrfS mns tad hyrhr tlate.aawct cT’tnrdoteDsuaie ne nafGfpP erm ude dt,s a oaetttis. sgodt euomroiyurnnnr mfomrb renwti rddblFterr afoa n stcsh c H
no at b eMaeo e klteugtahtuy mrcupeu iatdnoba taetsv yheaes penawdAed.scoae chls ti edsoosan reivsit steet glnltyr rnetdhrnbor eaaoro trhorlhwdtsd gmt’p eataelD s Far
.tlrs ayy’“rertanbsrlnt djlavee rtie nefoe, crapg t eeasa iagr p te sd thta c hae”utWheiosta ln iannd de
Feedc r nsneiesr.RfHe sae steepdjdrtatm a anvndgSdaeriwimranbtdA ah cgn rte ee tbayKlay“Fhsaehr yrhftptut’eau.np y inc ”eH otJabMo c.er porolheahoeDt a pr nulkslyrTeeSsceigfiraul i aennn dw cbkib tdi irys
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.